Dynepo (Epoetin delta)

DRUG2 trials

Sponsors

Shire

Conditions

AnemiaKidney DiseasesKidney FailureKidney Failure, ChronicRenal Failure, Chronic

Phase 3

Dynepo Infrequent Dosing Study

TerminatedNCT00450333

ShireAnemia, Kidney Failure

Start: 2006-10-30End: 2008-07-31Updated: 2021-06-14

Unknown Phase

DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)

TerminatedNCT00664066

ShireAnemia, Kidney Diseases, Kidney Failure, Chronic +1

Start: 2008-04-25End: 2008-07-30Updated: 2021-06-25

Related Papers

Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial.

2007-11-134 citations